Artiva Biotherapeutics shares fell 30% in pre-market trading after halting cell therapy following the deaths of two patients and laying off 94% of its workforce.

2026-10-27

Artiva Biotherapeutics shares fell 30% in pre-market trading after halting cell therapy following the deaths of two patients and laying off 94% of its workforce.